Today: 28 February 2026
Subscribe
Browse Category

NASDAQ:SNDL 4 November 2025 - 15 December 2025

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Stock Surges as Trump Schedule III Buzz Collides With New Vape Launch and Reverse Split Fallout

Tilray Brands shares surged December 15 as global cannabis stocks rallied on reports that Donald Trump may push to reclassify marijuana as a Schedule III drug. The move, which would ease federal restrictions but stop short of legalization, fueled investor optimism over potential tax and banking benefits for the industry. Tilray also completed a 1-for-10 reverse stock split and reported momentum in its Canadian portfolio.
15 December 2025
····
SNDL Stock Jumps on Marijuana Rescheduling Headlines: Latest News (Dec. 12, 2025), Forecasts, and What Investors Are Watching

SNDL Stock Jumps on Marijuana Rescheduling Headlines: Latest News (Dec. 12, 2025), Forecasts, and What Investors Are Watching

SNDL Inc. shares rose sharply Friday after reports that the Trump administration may seek to reclassify marijuana as a Schedule III drug. The Washington Post and Reuters said no final decision has been made, but the move could ease research restrictions and improve industry economics. SNDL was among the top cannabis gainers in premarket trading.
12 December 2025
·
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?

SNDL Inc. shares fell 12% to $1.93 on Nov. 4 after reporting a Q3 net loss of C$11.1 million despite record free cash flow and 3.1% revenue growth to C$244.2 million. The stock is up about 10% year-to-date but down nearly 15% in the past month. SNDL holds C$240.6 million in cash and no debt. Analyst consensus remains “Hold” with a $2.50 price target.
4 November 2025
···
Go toTop